The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-(2-(1-(2-(4-(4-fluorobenzoyl)piperazin-1-yl)ethyl)pyrrolidin-3-ylamino)-2-oxoethyl)-3-(trifluoromethyl)benzamide ID: ALA1093154
PubChem CID: 46885160
Max Phase: Preclinical
Molecular Formula: C27H31F4N5O3
Molecular Weight: 549.57
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCN2CCN(C(=O)c3ccc(F)cc3)CC2)C1
Standard InChI: InChI=1S/C27H31F4N5O3/c28-22-6-4-19(5-7-22)26(39)36-14-12-34(13-15-36)10-11-35-9-8-23(18-35)33-24(37)17-32-25(38)20-2-1-3-21(16-20)27(29,30)31/h1-7,16,23H,8-15,17-18H2,(H,32,38)(H,33,37)/t23-/m1/s1
Standard InChI Key: RBXZKCFVNNEGGD-HSZRJFAPSA-N
Molfile:
RDKit 2D
39 42 0 0 0 0 0 0 0 0999 V2000
10.7200 -16.4195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7187 -17.2472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4323 -17.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1523 -17.2467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1492 -16.4156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4303 -16.0089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8608 -16.0024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5757 -16.4097 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.8574 -15.1773 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.5751 -15.5809 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.0065 -16.0095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0063 -15.1844 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2934 -16.4199 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5800 -16.0098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8622 -16.4203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1488 -16.0103 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8625 -17.2453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4313 -16.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6472 -16.1734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1767 -16.8469 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6671 -17.5060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4487 -17.2427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3518 -16.8592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9264 -16.1522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1014 -16.1598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6809 -15.4456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8597 -15.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4515 -16.1731 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8755 -16.8867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7035 -16.8784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6263 -16.1819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2238 -16.8996 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2084 -15.4686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6123 -14.7523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1952 -14.0441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6308 -14.0479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0378 -14.7755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6135 -15.4806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0498 -13.3396 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4 5 1 0
7 10 1 0
2 3 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
1 11 1 0
20 23 1 0
5 6 2 0
23 24 1 0
11 12 2 0
24 25 1 0
25 26 1 0
6 1 1 0
11 13 1 0
1 2 2 0
13 14 1 0
5 7 1 0
25 30 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
14 15 1 0
28 31 1 0
3 4 2 0
31 32 2 0
15 16 1 0
31 33 1 0
7 8 1 0
33 34 2 0
15 17 2 0
34 35 1 0
35 36 2 0
18 16 1 6
36 37 1 0
18 19 1 0
37 38 2 0
38 33 1 0
7 9 1 0
36 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 549.57Molecular Weight (Monoisotopic): 549.2363AlogP: 2.22#Rotatable Bonds: 8Polar Surface Area: 84.99Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.02CX LogP: 1.88CX LogD: 1.17Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.49Np Likeness Score: -1.94
References 1. Lim JW, Oh Y, Kim JH, Oak MH, Na Y, Lee JO, Lee SW, Cho H, Park WK, Choi G, Kang J.. (2010) Synthesis and biological evaluation of 3-aminopyrrolidine derivatives as CC chemokine receptor 2 antagonists., 20 (7): [PMID:20223662 ] [10.1016/j.bmcl.2010.02.072 ]